Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
Total reported revenue | 14.0M | — | 12.2M | 12.5M |
Cost of revenue | 11.7M | — | 12.2M | 9.9M |
Gross profit | 2.3M | — | -41K | 2.6M |
Operating expense | ||||
Research & development | 47.5M | — | 29.0M | 29.7M |
Selling general and admin | 10.9M | — | 8.0M | 7.6M |
Other operating expenses | — | — | — | — |
Operating income | -56.0M | — | -37.0M | -34.7M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | 18.7M | — | 6.1M | 13.9M |
Pretax income | -37.4M | — | -30.9M | -20.8M |
Tax provision | 0 | — | 2K | 0 |
Net income | -37.4M | — | -30.9M | -20.8M |
Basic EPS | -0.1 | -1.0 | — | -0.1 |
Diluted EPS | -0.1 | -1.0 | — | -0.1 |
Basic average shares | 351.7M | 182.3M | — | 349.0M |
Diluted average shares | 351.7M | 182.3M | — | 349.0M |
EBITDA | -78.2M | — | -42.2M | -46.5M |
Net income from continuing op. | — | — | — | — |
Minority interests | -5.6M | — | 227K | 231K |
Preferred stock dividends | — | — | — | — |